Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 2150 of 3499 entries
View as:

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Phase: N/A Priority: Normal
NCT ID: NCT00390455 Org: User:
Start: 09/15/06 End: 07/02/14 Due: 07/02/15

Non-Viral TCR Gene Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04102436 Org: User:
Start: 03/08/24 End: 03/08/24 Due: 03/08/25

Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00227760 Org: User:
Start: 12/31/05 End: 05/31/13 Due: 05/31/14

Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00253370 Org: User:
Start: 10/31/05 End: 09/30/10 Due: 09/30/11

Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00098540 Org: User:
Start: 12/31/04 End: - Due: -

A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00926640 Org: User:
Start: 07/01/09 End: 04/20/18 Due: 04/20/19

BMS-214662 in Treating Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00005973 Org: User:
Start: 04/30/00 End: - Due: -

Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01282333 Org: User:
Start: 01/31/11 End: - Due: -

Effect of Tenofovir DF on Bone Metabolism in Children

Phase: N/A Priority: Normal
NCT ID: NCT00088309 Org: User:
Start: 06/30/04 End: 05/31/06 Due: 05/31/07

FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00020202 Org: User:
Start: 06/30/00 End: 03/31/07 Due: 03/31/08

Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00084877 Org: User:
Start: 03/31/04 End: - Due: -

Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003190 Org: User:
Start: 01/31/98 End: - Due: -

Bevacizumab and Irinotecan to Treat Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00393094 Org: User:
Start: 09/30/06 End: 03/31/10 Due: 03/31/11

Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00039481 Org: User:
Start: 11/30/02 End: - Due: -

Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML

Phase: N/A Priority: Normal
NCT ID: NCT00895934 Org: User:
Start: 05/31/09 End: 09/30/13 Due: 09/30/14

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01349933 Org: User:
Start: 04/30/11 End: 10/31/13 Due: 10/31/14

Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis

Phase: N/A Priority: Normal
NCT ID: NCT00923832 Org: User:
Start: 03/30/09 End: 11/23/09 Due: 11/23/10

Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers

Phase: N/A Priority: Normal
NCT ID: NCT03402230 Org: User:
Start: 02/20/18 End: 07/24/22 Due: 07/24/23

FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00079443 Org: User:
Start: 01/31/04 End: - Due: -

Anal Cancer Screening Study

Phase: N/A Priority: Normal
NCT ID: NCT00914537 Org: User:
Start: 06/02/09 End: 11/04/20 Due: 11/04/21

Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00030368 Org: User:
Start: 11/30/01 End: - Due: -

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Sacituzumab Govitecan Alone in the Treatment of Advanced Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06524544 Org: User:
Start: 08/01/25 End: 12/31/28 Due: 12/31/29

Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT00012181 Org: User:
Start: 04/30/01 End: - Due: -

Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00005780 Org: User:
Start: 06/01/00 End: 06/16/21 Due: 06/16/22

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03354416 Org: User:
Start: 02/26/18 End: 12/31/33 Due: 12/31/34